Dasatinib
- Product NDC
- 70748-213
- 11-digit product format
- 707480213
- Labeler code
- 70748
- Product ID
- 70748-213_79f45560-3318-42e3-8be6-fac133dca745
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA214350
- Marketing category
- ANDA
- Marketing start
- 2026-01-30
- Substance
- DASATINIB
- Active strength
- 140 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dasatinib
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 140 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70748-213-06 | Dasatinib | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
| 70748-213-06 | Dasatinib | 1 in 1 CARTON | TABLET | 1 | | 7 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70748-213-06 | 70748021306 | 1 BOTTLE in 1 CARTON (70748-213-06) / 30 TABLET in 1 BOTTLE | 1 bottle | 2026-01-30 | No | No | Current |